510 likes | 619 Views
Overview of the Experience of Long-term Insurers in SA for 2008. Tienie Hamman 17/19 November 2009. Why are we here?.
E N D
Overview of the Experience of Long-term Insurers in SA for 2008 Tienie Hamman 17/19 November 2009
Why are we here? To provide information to industry on representative SA Statutory Valuation Method bases reported in 2008, including comparisons with previous years’ data and some comparisons with actual experience.
What will we show you? • Brief overview of the LT insurance market in 2008 • Review the representative: • Reported valuation assumptions (G10.x) and • Reported actual experience (B - statements) for certain key elements in a valuation basis
Overview: Number of insurers & total assets, split by year-end
Mortality • In the graphed rates, we tried to determine representative mortality rates • For assured lives we used 100% of the SA85/90 (heavy) ultimate table to place weighted rates into perspective • For annuitants we used 100% of the a(55) table to put weighted average rates into perspective
Mortality: Actual vs. expected • For assurance products: • Individual: 83% (81%) • Group: 89% (94%) • For annuity products: • Individual: 115% (114%) • Group: 97% (88%)
Morbidity: Actual vs. expected • For lump sum disability: • Individual: 74% (75%) • Group: 66% (65%) • For income disability: • Individual: 42% (28%) • Group: 68% (74%)
Assumed central discount rate Page 25
Actual expense inflation 9% 4% 21% 8% 22% 21% 3% 79%
Overview – CAR cover • Total CAR is 2.56% of total liabilities • This is a 4.36% increase from the previous year
Operational and Credit risk • Operational risk • Total amount of ± R4.6bn • Comprises 17% of total CAR held • Comprises 0.5% of total Assets • Credit risk • Total amount of ± R2.9bn • Comprises 10.7% of total CAR held • Comprises 0.3% of total Assets
Management Action • TCAR wasn’t reduced by management action • Elements of OCAR reduced: • Investment risk – reduced by 66% • Worst investment return – reduced by 42% • Resilience risk – reduced by 66% • Annuitant mortality fluctuation risk – reduced by 12% • Morbidity fluctuation risk – reduced by 11% • Operational risk - reduced by 3% • Credit risk – reduced by 23% • No reduction in Embedded Investment Derivatives Component